Market Research > Healthcare > Nonprescription Drugs USA

Market Research Reports: Nonprescription Drugs

Nonprescription Drugs USA
Data and Minor Companies to be published 1st qtr. 2013
Rest of written report to be published 2nd qtr. 2013
Base Year: 2012

Description
Regional Coverage: United States
Download Brochure
Download Fact Sheet

DESCRIPTION
A comprehensive analysis of the U.S. nonprescription drugs industry, focusing on key trends, developments, challenges, business opportunities, and new product activity, and offers insights and information on the following:
- Industry trends
- Market size and performance
- Brand sales and share
- Company sales and share
- New product activity
- Retail distribution
- Regulatory developments
- Rx-to-OTC switch forecasts
- Five-year historical sales
- Five-year sales forecasts
Features user-friendly database that is fully searchable and exportable that contains sales data, growth, share, and forecasts for hundreds of brands and companies across 36 categories.
Contents

TABLE OF CONTENTS

Introduction Executive Summary An executive briefing covering developments in 2012, the impact of key trends and issues in the nonprescription drug business, and their future implications for industry participants. Industry Analysis A summary of industry developments in 2012 and a five-year forecast. The market 2012 Companies Selling and distribution Private-label activity Outlook to 2017 Kline's FutureView forecasting scenarios The Products Pertinent information plus insightful analysis of approximately 36 major categories, including category trends and developments; manufacturers' sales for 2011 and 2012, sales and market shares for leading brands, new product activity, sales by retail channel, private-label sales, promotional activity, and outlook to 2017. The product categories that are covered are shown in Table 1 below. Major Companies Profiles for 15 major companies, including company activities; sales by product category and major brands in 2011 and 2012; recent developments including acquisitions, divestitures, and new products; corporate overview; and an outlook to 2017. The major companies that will be covered are shown in Table 2 below. Minor Companies Brief profiles of approximately 50 smaller marketers of nonprescription drugs, including corporate sales and profits; nonprescription drug sales, recent developments, including acquisitions, divestures, and new product activity, product portfolios, and traceable media expenditures for 2012. Advertising Traceable media expenditures with analysis by product category and by major company.

Table 1: Product Categories Profiled
Allergy, Asthma, and Sinus Products	Internal Analgesics
• Allergy relief products • Asthma medications • Sinus medications	• Arthritis pain relievers • General pain relievers • Menstrual relief products
Cough and Cold Preparations	Nutritional Products
• Cold medications • Cough drops and lozenges • Cough syrups • Nasal decongestants • Sore throat remedies • Topical vapor products	• Herbal products • Vitamins and minerals
	Topical Products
	• Anti-itch products • Corn, callus, and wart removers • Diaper rash products • Eye care products • First aid products • Fungicidal preparations • Hair regrowth treatments • Hemorrhoidal preparations • Oral care products • Topical analgesics
Digestive Products
• Antacids and antigas products • Antidiarrheal preparations • Antinausea preparations • Laxatives
Feminine Products
• Contraceptive products • Feminine deodorants and itching remedies • Feminine yeast infection remedies • Personal lubricants
	Other Products
	• Home diagnostic test kits • Sleeping aids • Smoking cessation aids • Weight loss medications

Table 1: Major Companies Profiled
Abbott Laboratories	Perrigo
Bayer	Pfizer
Boehringer-Ingelheim	Prestige Brands
GlaxoSmithKline	Procter & Gamble
Insight Pharmaceuticals	Reckitt Benckiser
Johnson & Johnson	Roche
Merck	Sanofi
Novartis

Scope
Nonprescription Drugs USA is an extensive industry resource used widely by marketing executives and other industry participants for competitive analysis, market investigation for new products, acquisition screening, and business planning.
For more than 40 years, the study has proven to be the most authoritative and comprehensive annual source of information on the nonprescription drug industry. It contains industry trends and market size data for 36 product categories. In addition, market share and brand sales information are reported. The study profiles 14 leading major companies. Included in the report is an analysis of regulatory developments, retail distribution, and private-label activity.
Key Benefits
Subscribers to Nonprescription Drugs USA are afforded the following benefits:
- Access to the most comprehensive and authoritative independent source of information and insights on the U.S. nonprescription drugs industry
- Access to accurate sales data through all outlets based on primary research with knowledgeable industry participants
- Invitation to participate in Kline's annual web conference with access to Kline's analysts and an in-depth presentation about market performance and industry trends
- A tool to learn about categories or brands that could be potential new entry/acquisition opportunities
- Access to periodic podcasts on timely topics from Kline's industry experts
- A source of valuable competitive information and intelligence
- Understand industry trends that may impact your categories and/or brands
- Learn about expected future Rx-to-OTC switches and their expected impacts on existing OTC categories
- Depth of knowledge with historical sales and trend information, as well as five-year sales forecasts
- Assessment of new product activity in each category
- Access to Kline’s searchable, exportable database with sales data on hundreds of brands and companies across36 categories
- Now includes findings from consumer research on key market trends
- Subscribers to this study are entitled to a discount on Kline's new Nonprescription Drugs USA Active Ingredients database
Methodology
Kline is unmatched in our ability to gather hard-to-get market and competitive intelligence with a high degree of accuracy. Kline's market analysis approach places the principal emphasis on primary research techniques to ensure that the foundation of business intelligence and insight is accurate, current, and reliable.
During the course of field research, Kline's professional staff of industry experts will conduct hundreds of in-depth discussions and personal interviews with a wide range of knowledgeable industry participants and opinion leaders, including nonprescription drug manufacturers, retailers, suppliers, and industry associations. This approach has proven to be the most effective and reliable approach to obtaining accurate market data, capturing expert insights, and identifying business opportunities. The report also includes findings from online consumer research conducted by Kline with over 300 consumers about their perceptions, usage, and purchase habits of OTC drugs.
Primary research comprises the bulk of the overall research methodology for this report. In addition, this analysis is supplemented by dedicated, full-time rigorous searches of secondary research drawn from the review of company materials such as financial filings and press releases, regular searches of trade and technical literature; Internet sources; store checks; and analysis of statistical data from government, industry, and trade associations and agencies.